The phrase "a second dose at" is correct and usable in written English.
It can be used when referring to the timing or location of receiving a second dose of a vaccine or medication.
Example: "You will need to schedule a second dose at the clinic two weeks after your first appointment."
Alternatives: "the second dose scheduled for" or "a follow-up dose at".
Now I can expect a second dose at Fourteenth Street.
The Bexsero vaccine is available on the NHS for babies aged two months, followed by a second dose at four months and a booster at 12 months.
Currently the vaccine is only offered to babies aged between two and five months, followed by a second dose at four months and a booster at 12 months.
A vaccine to protect against meningitis B is available on the NHS for babies aged two months, followed by a second dose at four months and a booster at 12 months.
The purified CD4+CD62L+ Tregs (mCD4CD62L Tregs, 3×106 cells) were administered intraperitoneally into overt diabetic NOD mice in 100 µl PBS/mouse (i.p., close to pancreas) for the first dose, followed by a second dose at 2 million cells in 100 µl PBS/mouse (i.p., close to pancreas) one week later.
One possibility is to vaccinate before nine-months of age and provided a second dose at a later age.
A stronger dosage of the vaccine, often referred to as DTaP, is recommended for all infants, and is usually given at ages 2, 4 and 6 months with a fourth dose at about 15 to 18 months.
PRP-OMP conjugate vaccines induce a strong immune response with a first dose at 2 months of age and are given as a 2-dose primary series (24 ).
The Australian standard vaccination schedule for pertussis consists of acellular vaccines given in doses at 2, 4 and 6 months, followed by a fourth dose at 4 years and a booster at 15 17 years of age [ 1].
The standard three-dose schedule is 0, 1, and 6 months, although an accelerated schedule of 0, 1, and 4 weeks offers good short-term protection but requires a fourth dose at 1 year.
Other studies, however, using a third dose at the end of the day did find a greater sleep-onset delay in children treated with stimulants compared to untreated subjects [ 7, 137].
